Feng‐Chih Shen

Dulaglutide and cardiovascular outcomes in type 2 diabetes (REWIND): a double-blind, randomised placebo-controlled trial

Hertzel C. Gerstein, Helen M. Colhoun, Gilles R. Dagenais et al. · The Lancet · 2019 · 2.8K citations · Full text

Metabolic Syndrome, Diabetes Management, Cardiovascular Disease +9

Dulaglutide and renal outcomes in type 2 diabetes: an exploratory analysis of the REWIND randomised, placebo-controlled trial

Hertzel C. Gerstein, Helen M. Colhoun, Gilles R. Dagenais et al. · The Lancet · 2019 · 600 citations · Full text

Metabolic Syndrome, Diabetes Management, Urology +10

Glucagon-like peptide 1 improves insulin resistance in vitro through anti-inflammation of macrophages

Chenyu Guo, Tianhao Huang, A. Chen et al. · Brazilian Journal of Medical and Biological Research · 2016 · 95 citations · Full text

Immunology, Immune Regulation, Insulin Signaling +21

The Causal Role of Mitochondrial Dynamics in Regulating Insulin Resistance in Diabetes: Link through Mitochondrial Reactive Oxygen Species

Hung‐Yu Lin, Shao‐Wen Weng, Yen‐Hsiang Chang et al. · Oxidative Medicine and Cellular Longevity · 2018 · 79 citations · Full text

Mitochondrial Dysfunction, Mitochondrial Biology, Metabolic Remodeling +18

Effects of Resistance Exercise on Glycated Hemoglobin and Functional Performance in Older Patients with Comorbid Diabetes Mellitus and Knee Osteoarthritis: A Randomized Trial

Shu‐Mei Chen, Feng‐Chih Shen, Jung‐Fu Chen et al. · International Journal of Environmental Research and Public Health · 2019 · 50 citations · Full text